Bemotrizinol will initially be sold in the U.S. by the Dutch manufacturer DSM Nutritional Products under the brand name Parsol Shield, which is expected to launch later in the year.
The first pediatric guidelines from the American Academy of Dermatology include 27 recommendations on atopic dermatitis. They confirm the arrival of new treatment options, without relegating basic therapies to a secondary role.
Dr. Jennifer Knox, medical director of the pancreatic cancer clinic at Princess Margaret Cancer Centre in Toronto, said she hopes to start a clinical trial of the experimental medication daraxonrasib and other related drugs at her centre in the coming months.
Study identifies which of the five major antihypertensive drug classes is associated with the lowest rates of medication discontinuation due to adverse events.
In two international studies, about one in five patients given the experimental drug saw their virus reduced to levels low enough for the immune system to keep in check.
